ARIAKE JAPAN Co.,Ltd.

Business Details

Ariake Japan operates a single segment engaged solely in the manufacture and sale of natural seasonings. In addition to domestic plants, the company has established a seven-region global production network spanning China, Taiwan, France, Belgium, the Netherlands, and Indonesia, enabling optimal-location production. Its core products are liquid natural seasonings, marketed to food manufacturers and food-service/prepared-food customers under the value proposition of "food safety, health, and great taste." In FY2026 (ending March 2026), consolidated net sales reached ¥66,957 million, with regional diversification advancing: Japan ¥48,456 million, Europe ¥8,461 million, China ¥6,247 million, and Asia (excluding China) ¥3,792 million.

Recent Overview

Achieved higher sales and profit, with expanded foreign exchange gains significantly boosting ordinary profit; also implemented a commemorative dividend for the company's 60th anniversary

In FY2026 (ending March 2026), the company achieved higher sales and profit, with consolidated net sales of ¥66,957 million (up 2.4% year on year) and consolidated operating profit of ¥11,782 million (up 6.0% year on year). Ordinary profit rose substantially to ¥13,757 million (up 14.6% year on year), boosted by a ¥662 million year-on-year increase in foreign exchange gains. By region, sales in Europe expanded to ¥8,461 million (up approximately 16% from ¥7,273 million in the prior year). Regarding changes in the scope of consolidation, Ariake U.S.A., Inc. was newly consolidated, while Ariake (Rizhao) Foods Co., Ltd. was excluded. As a subsequent event, the company resolved to acquire treasury shares (up to 1 million shares, with a total acquisition price cap of ¥6,000 million). For FY2027 (ending March 2027), the company forecasts net sales of ¥69,232 million (up 3.4% year on year), while operating profit is expected to decline to ¥11,251 million (down 4.5% year on year).

Key Products

Growth Drivers

• Sales at European subsidiaries expanded approximately 16% year on year to ¥8,461 million (contribution from Belgian and French operations)
• Global expansion of demand for natural extracts driven by health consciousness and demand for natural ingredients
• Improved operating margin (from 17.0% to 17.6%) through cost reductions and production efficiency gains
• Optimal-location production under the seven-region global framework and strategic raw material procurement from overseas subsidiaries
• Strengthened sales to processing manufacturers in the China/Taiwan markets and expanded raw material supply from Indonesia
• Expansion into the U.S. market through the newly consolidated Ariake U.S.A., Inc.

Risks

• Cost increase risk from fluctuations in livestock-based raw material prices (continued elevated raw material and packaging material costs)
• Impact on business performance and financial condition from sharp foreign exchange fluctuations (raw material imports from overseas subsidiaries)
• Impact on foreign exchange markets and resource prices from geopolitical risks and factors such as U.S. trade tariffs
• Limits on sales growth in the domestic market due to declining birthrate, an aging population, and stronger consumer cost-consciousness
• Risk of rising capital expenditure costs associated with overseas plant expansions and new plant construction (operating profit forecast to decline in FY2027, ending March 2027)
• Continued pressure on profitability from rising logistics costs, labor costs, and energy costs